Jews

• 

  Subject Areas on Research

  • A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. 
  • A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations. 
  • A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans. 
  • A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients. 
  • Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. 
  • An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. 
  • BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. 
  • BRCA mutations and risk of prostate cancer in Ashkenazi Jews. 
  • Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. 
  • Central nervous system lymphoma in immunocompetent patients: the North Shore-Long Island Jewish Health System experience. 
  • Characterization of BRCA1 and BRCA2 mutations in a large United States sample. 
  • Consistent long-range linkage disequilibrium generated by admixture in a Bantu-Semitic hybrid population. 
  • Cystic fibrosis in Jews: frequency and mutation distribution. 
  • Defining the polyposis/colorectal cancer phenotype associated with the Ashkenazi GREM1 duplication: counselling and management recommendations. 
  • Discerning the ancestry of European Americans in genetic association studies. 
  • Founding mothers of Jewish communities: geographically separated Jewish groups were independently founded by very few female ancestors. 
  • Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. 
  • Hereditary ovarian cancer in Ashkenazi Jews. 
  • Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. 
  • Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease. 
  • Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. 
  • Increased risk for familial ovarian cancer among Jewish women: a population-based case-control study. 
  • Jewish physicians' beliefs and practices regarding religion/spirituality in the clinical encounter. 
  • Making Sausage. 
  • Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveys. 
  • Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls. 
  • Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. 
  • Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes. 
  • Nonsyndromic Retinitis Pigmentosa in the Ashkenazi Jewish Population: Genetic and Clinical Aspects. 
  • Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. 
  • Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. 
  • Primary care physicians' and psychiatrists' willingness to refer to religious mental health providers. 
  • RFLPs for linkage analysis in families with glycogen storage disease type III. 
  • Race/ethnicity, socioeconomic characteristics, coethnic social ties, and health: evidence from the national Jewish population survey. 
  • Religion and United States physicians' opinions and self-predicted practices concerning artificial nutrition and hydration. 
  • Religious affiliations in mental health research samples as compared with national samples. 
  • Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. 
  • Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management. 
  • The Jewish problem in U.S. medical education, 1920-1955. 
  • The cult of Franz Boas and his "conspiracy" to destroy the white race. 
  • Y chromosomes traveling south: the cohen modal haplotype and the origins of the Lemba--the "Black Jews of Southern Africa".